As such, mutations in the genes encoding for ENDOGLIN (ENG) and ALK1 (ACVRL1) result in the pathogenesis of HHT in 90% of the patients (McAllister et al., 1994; Johnson et al., 1996). This evidence concerns the gene ALK and hereditary hemorrhagic telangiectasia.